Home › Funds › KING STREET CAPITAL MANAGEMENT, L.P. › SGRY

KING STREET CAPITAL MANAGEMENT, L.P. position in SGRY

SURGERY PARTNERS INC · Health Care

KING STREET CAPITAL MANAGEMENT, L.P. reported holding 6,058,141 shares of SGRY (SURGERY PARTNERS INC) in its Q2 2026 13F filing — a position valued at US$101.8M, representing 53.66% of its reported portfolio and ranking #1 among its reported holdings. KING STREET CAPITAL MANAGEMENT, L.P. has disclosed SGRY holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)6.06M sh
Reported value held$101.78M
Portfolio Weight53.66%
First reportedQ3 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How KING STREET CAPITAL MANAGEMENT, L.P.'s SGRY position evolved

KING STREET CAPITAL MANAGEMENT, L.P. first disclosed a stake in SGRY in Q3 2024 at 1,450,000 shares (US$46.7M). The position peaked in Q3 2025 at 9,339,930 shares, worth US$202.1M. Across 8 filings, KING STREET CAPITAL MANAGEMENT, L.P. increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 6,058,141 shares valued at US$101.8M — a reduction of -4,171,589 shares quarter over quarter.. Notable position changes include a 93% increase in Q4 2024 (shares rose 12% over the following quarter), a 79% increase in Q1 2025 (shares fell 6% over the following quarter), a 50% increase in Q3 2025 (shares fell 29% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 1.45M $46.75M New
Q4 2024 2.80M $59.28M Add
Q1 2025 5.00M $118.75M Add
Q2 2025 6.22M $138.38M Add
Q3 2025 9.34M $202.12M Add
Q4 2025 10.23M $158.05M Add
Q1 2026 10.23M $121.94M Hold
Q2 2026 6.06M $101.78M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SGRY and 13F data

SGRY (SURGERY PARTNERS INC) is a Health Care company. 33 other funds we track also report a position in SGRY — the largest reported positions include BAIN CAPITAL INVESTORS LLC (US$839.1M), Pentwater Capital Management LP (US$195.4M), Davidson Kempner Capital Management (US$56.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SGRY

All SGRY fund holders →

FAQ

How long has KING STREET CAPITAL MANAGEMENT, L.P. held SGRY?

KING STREET CAPITAL MANAGEMENT, L.P. has disclosed SGRY holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is KING STREET CAPITAL MANAGEMENT, L.P.'s current position in SGRY?

As of Q2 2026, KING STREET CAPITAL MANAGEMENT, L.P. holds 6.06M shares of SGRY (SURGERY PARTNERS INC), valued at $101.78M, representing 53.66% of its reported portfolio and ranking #1.

Has KING STREET CAPITAL MANAGEMENT, L.P. been buying or selling SGRY?

In the latest 13F filing (Q2 2026), KING STREET CAPITAL MANAGEMENT, L.P. reduced its position in SGRY. The position peaked in Q3 2025 at 9.34M shares.

Which other funds hold SGRY?

Other major institutional holders of SGRY include BAIN CAPITAL INVESTORS LLC, Pentwater Capital Management LP, Davidson Kempner Capital Management, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.